-
Patient Preference and Adherence
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
A closer look at the baseline-observation-carried-forward (BOCF)
Original Research
(3307) Views (677) Full article downloads
Authors: Hong Liu-Seifert, Shuyu Zhang, Deborah D’Souza, et al
Published Date January 2010
Volume 2010:4 Pages 11 - 16
DOI: http://dx.doi.org/10.2147/PPA.S8135
Hong Liu-Seifert, Shuyu Zhang, Deborah D’Souza, Vladimir Skljarevski
Lilly Research Laboratories, Indianapolis, IN, USA
Purpose: The baseline-observation-carried-forward (BOCF) approach is one method to handle missing data from early treatment discontinuation. We examined modifications of this approach, taking into consideration treatment-related and nontreatment-related reasons for discontinuation.
Methods: Two duloxetine chronic pain trials (placebo-controlled) were used to examine the impact of different analytical methods on study outcome. Reasons for discontinuation were categorized as treatment-related and nontreatment-related. Missing data in the primary efficacy outcome were handled using five statistical methods: mixed-model repeated measures (MMRM), last-observation-carried-forward (LOCF), BOCF, modified BOCF (mBOCF, discontinuation due to treatment-related reasons, ie, adverse events [AEs] or lack of efficacy), and aeBOCF (discontinuation due to AEs only).
Results: Duloxetine was superior to placebo on mean change from baseline in Brief Pain Inventory average pain rating, using MMRM (study 1, P = 0.004; study 2, P < 0.001), LOCF (study 1, P = 0.019; study 2, P < 0.001), BOCF (study 1, P = 0.019; study 2, P = 0.013), and mBOCF (study 1, P = 0.041; study 2, P = 0.005). Using aeBOCF, duloxetine was superior to placebo in study 2 (P = 0.005) and numerically better in study 1 (P = 0.075).
Conclusion: Due to the different assumptions made by various methods regarding accounting for missing data, the analytical methods chosen may influence the interpretation of study results. Consideration should be given to the effect of actual treatment outcomes from patients. Employing different statistical approaches such as sensitivity analyses may help to assess the robustness of the study results and provide a more accurate reflection of the treatment outcome.
Keywords: discontinuation, treatment-related, pain, statistical
- 8th Annual Patient Adherence, Communications & Engagement Summit
31 May - 1 June 2011, Hotel Concorde, Berlin
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Health literacy and health seeking behavior among older men in a middle-income nation
- Increasing access to quality health care for the poor: Community perceptions on quality care in Uganda
- Prolonged rupture of membranes in term infants: should all babies be screened?
- Narcissistic rage: The Achilles’ heel of the patient with chronic physical illness




